Skip to content
10-Q

Quarterly Report

Whitehawk Therapeutics, Inc. WHWK

0000950170-25-105081

← back to feed
Filed
Aug 7, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 4, 2025 47.13M sh
Shares Diluted Q2 2025 · Jun 30, 2025 69.08M sh
Shares Diluted Q2 2025 · Jun 30, 2025 54.91M sh
Shares Diluted Q2 2025 · Jun 30, 2024 27.01M sh
Shares Diluted Q2 2025 · Jun 30, 2024 27M sh
Capex Q2 2025 · Jun 30, 2025 $552K
Capex Q2 2025 · Jun 30, 2024 $1.28M
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$64.82M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$28.81M
Short Term Investments Q2 2025 · Jun 30, 2025 $32.26M
Short Term Investments Q2 2025 · Dec 31, 2024 $18.57M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $144.94M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $28.67M
Stockholders Equity Q2 2025 · Jun 30, 2025 $172.07M
Stockholders Equity Q2 2025 · Mar 31, 2025 $221.73M
Stockholders Equity Q2 2025 · Dec 31, 2024 $52.48M
Stockholders Equity Q2 2025 · Jun 30, 2024 $78.79M
Stockholders Equity Q2 2025 · Mar 31, 2024 $90.46M
Stockholders Equity Q2 2025 · Dec 31, 2023 $105.2M
Current Liabilities Q2 2025 · Jun 30, 2025 $8.76M
Current Liabilities Q2 2025 · Dec 31, 2024 $17.07M
Total Liabilities Q2 2025 · Jun 30, 2025 $8.76M
Total Liabilities Q2 2025 · Dec 31, 2024 $17.84M
Current Assets Q2 2025 · Jun 30, 2025 $178.67M
Current Assets Q2 2025 · Dec 31, 2024 $61.29M
Total Assets Q2 2025 · Jun 30, 2025 $180.82M
Total Assets Q2 2025 · Dec 31, 2024 $70.32M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.76
Eps Diluted Q2 2025 · Jun 30, 2025 $0.37
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.54
Eps Diluted Q2 2025 · Jun 30, 2024 −$1.22
Eps Basic Q2 2025 · Jun 30, 2025 −$0.76
Eps Basic Q2 2025 · Jun 30, 2025 $0.37
Eps Basic Q2 2025 · Jun 30, 2024 −$0.54
Eps Basic Q2 2025 · Jun 30, 2024 −$1.22
Sga Expense Q2 2025 · Jun 30, 2025 $5.94M
Sga Expense Q2 2025 · Jun 30, 2025 $18.76M
Sga Expense Q2 2025 · Jun 30, 2024 $7.89M
Sga Expense Q2 2025 · Jun 30, 2024 $18.51M
Rd Expense Q2 2025 · Jun 30, 2025 $48.81M
Rd Expense Q2 2025 · Jun 30, 2025 $57.6M
Rd Expense Q2 2025 · Jun 30, 2024 $13.09M
Rd Expense Q2 2025 · Jun 30, 2024 $26.69M
Net Income Q2 2025 · Jun 30, 2025 −$52.62M
Net Income Q2 2025 · Jun 30, 2025 $20.4M
Net Income Q2 2025 · Mar 31, 2025 $73.02M
Net Income Q2 2025 · Jun 30, 2024 −$14.58M
Net Income Q2 2025 · Jun 30, 2024 −$32.87M
Net Income Q2 2025 · Mar 31, 2024 −$18.29M
Operating Income Q2 2025 · Jun 30, 2025 −$54.75M
Operating Income Q2 2025 · Jun 30, 2025 −$69.97M
Operating Income Q2 2025 · Jun 30, 2024 −$15.58M
Operating Income Q2 2025 · Jun 30, 2024 −$35.1M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $0
Cost Of Revenue Q2 2025 · Jun 30, 2025 $760K
Cost Of Revenue Q2 2025 · Jun 30, 2024 $778K
Cost Of Revenue Q2 2025 · Jun 30, 2024 $1.43M
Revenue Q2 2025 · Jun 30, 2025 $0
Revenue Q2 2025 · Jun 30, 2025 $7.15M
Revenue Q2 2025 · Jun 30, 2024 $6.18M
Revenue Q2 2025 · Jun 30, 2024 $11.53M